Nuclear export of the NF-κB inhibitor IκBα is required for proper B cell and secondary lymphoid tissue formation

Shelly M. Wuerzberger-Davis, Yuhong Chen, David T. Yang, Jeffrey D. Kearns, Paul W. Bates, Candace Lynch, Nicholas C. Ladell, Mei Yu, Andrew Podd, Hu Zeng, Tony T. Huang, Renren Wen, Alexander Hoffmann, Demin Wang, Shigeki Miyamoto

Research output: Contribution to journalComment/debate

9 Scopus citations
Original languageEnglish (US)
Number of pages1
JournalImmunity
Volume34
Issue number3
DOIs
StatePublished - Mar 25 2011

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases

Cite this

Wuerzberger-Davis, S. M., Chen, Y., Yang, D. T., Kearns, J. D., Bates, P. W., Lynch, C., Ladell, N. C., Yu, M., Podd, A., Zeng, H., Huang, T. T., Wen, R., Hoffmann, A., Wang, D., & Miyamoto, S. (2011). Nuclear export of the NF-κB inhibitor IκBα is required for proper B cell and secondary lymphoid tissue formation. Immunity, 34(3). https://doi.org/10.1016/j.immuni.2011.03.001